NHS

Showing 15 posts of 1107 posts found.

NICE releases reflux disease guidelines

January 15, 2015
Sales and Marketing NHS, NICE, UK, gor, gord, h2ra

NICE has released new guidelines providing doctors with advice on how to treat gastro-oesophageal reflux disease (GORD) in young people. …

dendreon image

Another NICE no for Dendreon cancer drug

January 13, 2015
Sales and Marketing Cancer, Dendreon, FDA, NHS, NICE, Provenge, sipuleucel-T

Dendreon has seen its prostate cancer treatment for people whose disease has spread and who are not yet suitable for …

NHS drops 25 treatments from Cancer Drugs Fund

January 12, 2015
Sales and Marketing Afinitor, CDF, Cancer, Cancer Drugs Fund, Eisa, Halaven, Heribulin, Jevtana, NHS, Sanofi, Zaltrap, aflibercept, cabazitaxel, everolimus

Twenty-five cancer treatments will be removed from the Cancer Drugs Fund list, NHS England has announced. Having concluded its review …

AZ image

AstraZeneca drops CDF application

January 12, 2015
Sales and Marketing AstraZeneca, CDF, Cancer, NHS, NICE, lynparza, olaparib

AstraZeneca has withdrawn its application for its drug Lynparza to be on the Cancer Drugs Fund (CDF), citing concerns with …

NHS image

NHS searches for healthcare innovators

January 8, 2015
Medical Communications, Sales and Marketing NHS, UK, innovation, programme, sir bruce keogh

NHS England and medical director Sir Bruce Keogh have launched an NHS Innovation Accelerator Programme. The initiative will invite healthcare …

Afinitor image

Exclusive: Novartis drug struck off cancer drugs fund

January 8, 2015
Sales and Marketing Afinitor, Jevtana, NHS, NHS England, NICE, Novartis, Sanofi, everolimus

Novartis’ Afinitor (everolimus) will be removed from the Cancer Drugs Fund list when NHS England announces which drugs it can …

NHS image

NHS plans bashed over cancer and heart disease

December 24, 2014
Research and Development, Sales and Marketing Cancer, England, NHS, Simon Stevens, funding, heart

Hundreds of healthcare experts have signed an open letter to NHS chief executive Simon Stevens calling for him to scrap …

Entyvio image

NICE rejects Takeda Crohn’s disease drug

December 23, 2014
Sales and Marketing Crohn’s disease, Entyvio, NHS, NICE, Takeda, crohn's disease, vedolizumab

Takeda has seen its treatment for people with Crohn’s disease Entyvio rejected by NICE in an initial appraisal. The healthcare …

NHS not au fait with mobile-savvy patients

December 19, 2014
Medical Communications, Sales and Marketing NHS, app, digital, health, mobile, smartphones, wearables

The NHS is failing to keep up with its digital generation of patients, a recent study has found.  Despite a …

Janssen image

Janssen launches HIV combination pill

December 17, 2014
Research and Development, Sales and Marketing BMS, Gilead, HIV, Janssen, NHS, NICE, rezolsta, tybost

Janssen has launched its HIV therapy Rezolsta in the UK, which combines its own Prezista with Gilead’s Tybost. Prezista (darunavir) …

Pradaxa image

Boehringer gets NICE nod for Pradaxa

December 16, 2014
Sales and Marketing Boehringer, NHS, NICE, Pradaxa, VTE, dagibatran, ingelheim, warfarin

NICE has confirmed a recommendation for Boehringer Ingelheim’s controversial anti-blood clotting drug Pradaxa, as a treatment for blood clots in …

Janssen image

Patient access schemes ‘lack transparency’

December 12, 2014
Research and Development, Sales and Marketing Janssen, NHS, NICE, Velcade, patient access, pharma, scheme

Deals negotiated between the pharma industry and governments to allow patients access to innovative new cancer treatments risk failing because …

NICE changes insulin advice in diabetes guidelines

December 12, 2014
Sales and Marketing NHS, NICE, diabetes, health survey, insulin, type 1, type 2

NICE has changed its recommendations on type 1 diabetes in adults and children, and type 2 diabetes in children, to …

Prescriptions image

Half of England on prescription drugs

December 11, 2014
Sales and Marketing England, HSCIC, NHS, doctors, prescribing, prescriptions

Almost half of the people in England are taking regular prescription medicines according to a new report by the Health …

Private firms account for a third of NHS contracts

December 10, 2014
Medical Communications, Sales and Marketing Budget, Cameron, Hunt, NHS, Osborne, autumn, election, privatisation

A large percentage of NHS contracts in England have been awarded to private sector providers since 2013, according to data …

The Gateway to Local Adoption Series

Latest content